MedTrace Logo

Cognitive Remediation Therapy Within a Secure Forensic Setting

NCT02360813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2017-07-25

No results posted yet for this study

Summary

This clinical trial tests the feasibility, effectiveness and patient satisfaction with cognitive remediation therapy for patients diagnosed with schizophrenia or schizoaffective disorder within a forensic hospital. It is hypothesised that patients receiving cognitive remediation therapy will have an improvement in cognitive performance, real world functioning, symptoms, violence risk and benefit more from additional psychosocial treatment programmes over time relative to patients receiving treatment as usual. Furthermore it is hypothesised that it will be feasible to carry out such a study and that patients will report high rates of satisfaction with cognitive remediation therapy. Finally it is hypothesised that differences on the effectiveness measures will be maintained at 6 month follow up after the end of treatment.

Conditions

Interventions

BEHAVIORAL

Cognitive Remediation Therapy

Fifty-six sessions of principle driven cognitive remediation therapy. Three individual sessions and one group session each week for approximately fourteen weeks.

OTHER

Treatment as usual

Keep getting usual care.

Sponsors & Collaborators

  • Central Mental Hospital

    lead OTHER_GOV

Principal Investigators

  • Professor Harry G Kennedy, M.D. · Central Mental Hospital and Department of Psychiatry, Trinity College Dublin.

  • Professor Gary Donohoe, Ph.D. · Department of Psychiatry, Trinity College Dublin.

  • Dr. Ken W O'Reilly, D.Psych.Sc. · Central Mental Hospital and Department of Psychiatry, Trinity College Dublin.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360813 on ClinicalTrials.gov